Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UB-851 vs Eprex in Renal Anemia on Hemodialysis
NCT02708914Phase 3Completed
- Sponsor
- UBI Pharma
- Start
- Mar 2016
- Primary completion
- Oct 2021
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of erythropoietin in anemia of chronic kidney disease, sponsored by UBI Pharma. Started Mar 2016; status: completed.
02
Drugs
erythropoietin
03
Conditions
anemia of chronic kidney disease
Beyond the preview
Go deeper on NCT02708914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02708914.